Jim Faulkner is an angel investor based in London, England, United Kingdom. The known portfolio counts 2 companies: Ascidian Therapeutics and Vitarka Therapeutics.
Is Jim Faulkner a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Seed
- Sector
- Healthcare
- Focus
- BiotechCellular TherapyDrug DiscoveryGene TherapyPharmaceuticals
Contacts
Jim Faulkner portfolio companies (2)
- Ascidian Therapeutics
- Vitarka Therapeutics
Investor Profile
The known portfolio sits in sector Healthcare, and focus areas Biotech, Cellular Therapy, Drug Discovery and Gene Therapy.
Stage-wise, the known deals cluster around Seed rounds.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Similar investors
Showing 20 of 100
Frequently asked questions
Who is Jim Faulkner?
Jim Faulkner is an angel investor based in London, England, United Kingdom with 2 known investments on file, among them Ascidian Therapeutics and Vitarka Therapeutics. The sections above list the sectors and stages attached to that record.
What does Jim Faulkner invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cellular Therapy, Drug Discovery and Gene Therapy. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Jim Faulkner invest at?
The known deals of Jim Faulkner include Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Jim Faulkner?
An email address, a phone number and a LinkedIn page are on file for Jim Faulkner. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 6 September 2026 · How this data is built · Report a correction or request removal
